Endothelium-independent vasorelaxation by ligusticum wallichii in isolated rat aorta: Comparison of a butanolic fraction and tetramethylpyrazine, the main active component of ligusticum wallichii

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 8, 2010, Pages 1360-1363

  Kim, Eun Young ^a   Kim, Jung Hyun ^a   Rhyu, Mee Ra ^a  

^a Korea Food Research Institute   (South Korea)

Author keywords

Calcium influx; Ligusticum wallichii; Potassium channel; Tetramethylpyrazine

Indexed keywords

4 AMINOPYRIDINE; APAMIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; CARDIOVASCULAR AGENT; GLIBENCLAMIDE; LINGUSTICUM WALLICHII EXTRACT; NIFEDIPINE; TETRAMETHYLPYRAZINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; LINGUSTICUM WALLICHII; MALE; MEDICINAL PLANT; MEMBRANE POTENTIAL; NONHUMAN; RAT; SMOOTH MUSCLE RELAXATION; TREATMENT RESPONSE; VASCULAR RING; VASODILATATION;

ANIMALS; AORTA, THORACIC; BUTANOLS; DRUGS, CHINESE HERBAL; ENDOTHELIUM, VASCULAR; LIGUSTICUM; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, VOLTAGE-GATED; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; TIME FACTORS; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 77956129929     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1360     Document Type: Article

References (29)

1. Chen K. J., Am. J. Chin. Med., 9, 193-196 (1981).
2. Chiou G. C. Y., Yan H. Y., Lei H. Y., Li B. H. P., Shen Z. F., Acta Pharmacol. Sin., 12, 99-104 (1991).
3. Liu J. Y., TianJin Pharm., 3, 29-31 (1991).
4. Hou Y. Zh., Zhao G. R., Yang J., Yuan Y. J., Zhua G. G., Hiltunen R., LifeSci., 75, 1775-1786 (2004).
5. Hou Y. Zh., Zhao G. R., Yuan Y. J., Zhua Z. Z., Hiltunen R., J. Ethnopharmcol., 100, 140-144 (2005).
6. Rhyu M. R., Kim E. Y., Kim B., Phytomedicine, 11, 51-55 (2004).
7. Koberstein R. C., Pittman D. E., Klocke F. J., Am. J. Physiol., 216, 531-534 (1969).
8. Lu C. S., Yin H. M., Hung T. H., Pao C., Sung C. F., Chin. Med. J., 4, 43-16 (1978).
9. Huang X., Zang Y., Wang Y., Niu G., Wen A., Ren P., Am. J. Chin. Med., 24, 169-176 (1996).
10. Tsai C. C., Lai Y. Y., Huang W. C., Liu I. M., Chen J. T., Life Sci., 71, 1321-1330 (2002).
11. Tsai C. C., Lai T. Y., Huang W. C., Yang T., Liu I. M., Wong K. L., Chan P., Chen J. T., Planta Med., 69, 557-558 (2003).
12. Wong K. L., Chan P., Huang W. C., Yang T., Liu I. M., Lai T. Y., Tsai C. C., Cheng J. T., Clin. Exp. Pharmacol. Physiol., 30, 793-798 (2003).
13. Faraci F. M., Heistad D. D., Physiol. Rev., 78, 53-97 (1998).
14. Gryglewski R. J., Palmer R. M. J., Moncada S., Nature (London), 320, 454-456 (1986).
15. Lüscher T. F., J. Hypertens., 12, S105-S116 (1994).
16. Nelson M. T., Quayle J. M., Am. J. Physiol., 268, C799-C822 (1995).
17. Standen N. B., Quayle J. M., Acta Physiol. Scand., 164, 549-557 (1998).
18. Sudjarwo S. A., Hori M., Karaki H., Eur. J. Pharmacol., 229, 137-142 (1992).
19. Brayden J. E., Clin. Exp. Pharmacol. Physiol., 23, 1069-1076 (1996).
20. Salom J. B., Burguete M. C., Pérez-Asensio F. J., Centeno J. M., Torre-grosa G., Alborch E., Steroids, 67, 339-346 (2002).
21. Hou Y. Zh., Yang J., Zhao G. R., Yuan Y. J., Eur. J. Pharmacol., 499, 85-90 (2004).
22. Li H. B., Chen F., J. Chromatogr. A, 1047, 249-253 (2004).
23. Chen X. G., Kong L., Su X. Y., Fu H. J., Ni J. Y., Zhao R. H., Zou H. R., J. Chromatogr. A, 1040, 169-178 (2004).
24. Liang M. J., He L. C., Yang G. D., Life Sci., 78, 128-133 (2005).
25. Ko W. C., Chang L. D., Wang G. Y., Lin L. C., Phytother. Res., 8, 321-326 (1994).
26. Kwan C. Y., Stem Cells, 12, 64-67 (1994).
27. Pang P. K., Shan J. J., Chiu K. W., Planta Med., 62, 431-435 (1996).
28. Ko F. N., Wu T. S., Liou M. J., Huang T. F., Teng C. M., Eur. J. Pharmacol., 219, 29-34 (1992).
29. Rhyu M. R., Kim J. H., Kim E. Y., J. Cardiovasc. Pharmacol., 46, 99-104 (2005).